National Intelligence Report

The Centers for Medicare and Medicare Services has declined to expand the Medicare Part B colorectal cancer screening benefit to include coverage of PreGen-Plus™ , a commercially available screening DNA stool test, as an alternative to a screening colonoscopy or a screening flexible sigmoidoscopy.